| Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis A Nagpal, RP Redvers, X Ling, S Ayton, M Fuentes, E Tavancheh, I Diala, ... Breast Cancer Research 21, 1-19, 2019 | 108 | 2019 |
| [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo ACBM Martin, AM Fuzer, AB Becceneri, JA da Silva, R Tomasin, ... Oncotarget 8 (42), 72260, 2017 | 68 | 2017 |
| Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer A Nagpal, K Needham, DJR Lane, S Ayton, RP Redvers, M John, ... Cancers 15 (4), 1216, 2023 | 5 | 2023 |
| Efficacy of neratinib neoadjuvant therapy in a pre-clinical model of HER2 (+ ve) breast cancer brain metastasis A Nagpal, RP Redvers, S Ayton, R Anderson, S Loi, N Pouliot ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 15, 61-61, 2019 | | 2019 |
| Limitrin (DICAM): a new prognostic biomarker and therapeutic target for breast cancer brain metastasis D Denoyer, SH Kim, RP Redvers, A Nagpal, M Fuentes, R Anderson, ... CLINICAL & EXPERIMENTAL METASTASIS 36 (2), 157-157, 2019 | | 2019 |
| Evaluation of Neratinib efficacy and mechanisms of resistance in a new syngeneic model of spontaneous breast cancer brain metastasis A Nagpal, RP Redvers, D Denoyer, SJ Ayton, H de Araujo, M Fuentes, ... CLINICAL & EXPERIMENTAL METASTASIS 36 (2), 145-145, 2019 | | 2019 |
| A novel approach to overcome resistance to HER2 targeted therapy in a new syngeneic model of breast cancer brain metastasis N Pouliot, A Nagpal, M Fuentes, E Mouhtouris, F Avogadri-Connors, ... Cancer Research 78 (13_Supplement), 1971-1971, 2018 | | 2018 |
